Global site-specific N-glycosylation analysis of HIV envelope glycoprotein. - Wikidata - wikimedia - TriplyDB

Global site-specific N-glycosylation analysis of HIV envelope glycoprotein.

Global site-specific N-glycosylation analysis of HIV envelope glycoprotein.

http://www.wikidata.org/entity/Q40276435

about

Identification of Fc gamma receptor glycoforms that produce differential binding kinetics for rituximab.Glycosylation profiling to evaluate glycoprotein immunogens against HIV-1.Glycans Function as Anchors for Antibodies and Help Drive HIV Broadly Neutralizing Antibody Development.cGMP production and analysis of BG505 SOSIP.664, an extensively glycosylated, trimeric HIV-1 envelope glycoprotein vaccine candidate.HIV Envelope Glycoform Heterogeneity and Localized Diversity Govern the Initiation and Maturation of a V2 Apex Broadly Neutralizing Antibody Lineage.Integrity of Glycosylation Processing of a Glycan-Depleted Trimeric HIV-1 Immunogen Targeting Key B-Cell Lineages.Benzyl-2-Acetamido-2-Deoxy-α-d-Galactopyranoside Increases Human Immunodeficiency Virus Replication and Viral Outgrowth Efficacy In Vitro.Exploiting glycan topography for computational design of Env glycoprotein antigenicity.Heterogeneity in glycan composition on the surface of HIV-1 envelope determines virus sensitivity to lectins.HIV envelope V3 region mimic embodies key features of a broadly neutralizing antibody lineage epitope.Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvant.The Hard Way towards an Antibody-Based HIV-1 Env Vaccine: Lessons from Other Viruses.Quantitative mass imaging of single biological macromolecules.Global site-specific analysis of glycoprotein N-glycan processing.Glycoengineering HIV-1 Env creates 'supercharged' and 'hybrid' glycans to increase neutralizing antibody potency, breadth and saturation.Co-evolution of HIV Envelope and Apex-Targeting Neutralizing Antibody Lineage Provides Benchmarks for Vaccine Design.Production of complex viral glycoproteins in plants as vaccine immunogens Site-Specific Glycosylation of Virion-Derived HIV-1 Env Is Mimicked by a Soluble Trimeric Immunogen The human naive B cell repertoire contains distinct subclasses for a germline-targeting HIV-1 vaccine immunogen CRISPR/Cas9 gene editing for the creation of an MGAT1-deficient CHO cell line to control HIV-1 vaccine glycosylation Differential processing of HIV envelope glycans on the virus and soluble recombinant trimer Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers

P2860

Q38747553-50FC1997-8432-4D9C-8A8A-35257D8F51A5 Q40058876-4703D6D7-9687-4058-B396-E2659E815736 Q41936503-30BC893F-12FB-4030-AFC5-172830165ED2 Q46067893-15506F47-BF6D-48CA-BF2A-558D8B574B69 Q46454115-7DB91728-04FB-4CC1-B2FA-BF12BDC1A174 Q50116524-3B754A28-1F1A-427A-9522-D4569D72A521 Q50334467-D68EF2CF-FCE8-4629-AD7B-F843F8208CAD Q52314288-07E0540B-288C-4C5A-822D-68645A558649 Q52341775-8B77B7AC-CB22-437B-9A5D-9C2AAE9E20E4 Q52352265-342D7175-129A-46B0-B344-5886114241F2 Q52561260-D7AF2B1A-7A2D-4197-A86C-1FD48CE61843 Q52584646-AFBACF21-0251-4368-BC61-3F8F4D2D1EF8 Q52804126-715D01CC-DFDA-4081-9102-0F5375B137AB Q53068939-3BE7E038-DFAE-49CA-A058-AC64E713048A Q53689028-215D69C2-6CD5-40C0-91B1-02A61814B61B Q55512707-FFD83977-6B6B-46CD-AADA-6108BDED196A Q56398263-C9B546AC-F377-4264-9875-10138F828CB9 Q57010966-44172371-2A80-4C7F-ADFF-962A869CF566 Q57094341-5FBEEF72-A033-4D84-9BA7-F1B93AB72619 Q58693500-40D3F0D3-0613-4504-9A8F-5F371975050F Q58747611-610564B5-05DA-42AF-91AA-8C8C7F257BB0 Q58763247-11B6C002-F1DE-4716-881F-73D5B333EB5A

P2860

Global site-specific N-glycosylation analysis of HIV envelope glycoprotein.

http://www.wikidata.org/entity/Q40276435

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Global site-specific N-glycosylation analysis of HIV envelope glycoprotein.

@en

type

label

Global site-specific N-glycosylation analysis of HIV envelope glycoprotein.

@en

prefLabel

Global site-specific N-glycosylation analysis of HIV envelope glycoprotein.

@en

P1433

Q40276435-D2827AD1-61F4-4B52-A9F8-7C6DE7E341A2

P1476

Q40276435-6AEA1D0B-8F1B-4C3E-8D8E-A5970CB2C54E

P2093

Q40276435-1937E177-E443-4C0E-9A55-5EEE97D71A5E

Q40276435-1A516D8F-5B0A-497B-9437-F4C7FDC89CD6

Q40276435-2F19672F-0CB5-4962-984F-C9D815DCD7BB

Q40276435-5D7D45CF-9139-45A8-8F4F-6D7621375CBE

Q40276435-60C08DB6-A2F4-4AB7-A34E-37CB909376E4

Q40276435-643CCC16-9361-44B0-8101-08B22D74F1B5

Q40276435-6B354B46-C4FA-489A-822A-7FEDF17ACCD0

Q40276435-77E59B74-1733-4BA2-9BF1-FDE05DD54A8C

Q40276435-7D995029-CA08-4F65-AE5D-E95EC541ED85

Q40276435-9237FED5-30A7-4D6A-9B4C-76D1954675DE

P2860

Q40276435-041F3663-0EFF-4737-AA0F-C3988A597771

Q40276435-065EEB40-2DC1-44B1-BB88-7B13C04637D2

Q40276435-0F96A265-7FA2-4AC6-A5ED-CE633EFD4328

Q40276435-10FE495C-40BA-49D8-9578-5CC9BAE11BC6

Q40276435-1118F58E-E929-4CA0-B022-BB970956043D

Q40276435-141BA025-2E10-4BA3-B9C1-9F8A977AC8D6

Q40276435-16230CE7-AF6B-47BB-8B5C-7EDA56BD62B8

Q40276435-18E02AB1-FCBF-441A-826F-EB41315E3C34

Q40276435-1B270DB9-9F5A-4480-9571-C6AA368CBF54

Q40276435-1D3A4462-2CC3-4139-B222-E6CBCAE7BCA4

P2888

Q40276435-AA1A331E-7CB4-4F9C-A3DE-F0D9AFF6BBFF

P304

Q40276435-8114207E-BB8B-4E71-B879-114F4E1A06EA

P31

Q40276435-FDC69822-167D-4EF2-B7C1-8B4A49EB0D69

P356

Q40276435-76C3C20A-6D9A-4EE4-9A04-87C0D9F91242

P407

Q40276435-3132B0C0-D66E-4E1F-B4B0-374EE0C6E70A

P478

Q40276435-95F66896-1D08-4FF5-A113-24FACE83E5FA

P50

Q40276435-BA2421F6-3875-4ED4-B716-1317AD8F91E3

Q40276435-D3D9D203-7FB9-4061-99E6-C7F394EAAD0B

P577

Q40276435-368A3ED4-E205-44C2-9AF1-09C77FDB86A1

P698

Q40276435-6E195CDC-C7C3-4A0D-99BB-E7469226A4E7

P921

Q40276435-26F6BA1A-79D2-42A0-92E9-B09FD0367C7D

P932

Q40276435-8B894F70-179E-44D1-9BCA-81FCE6615DE9

P356

P1433

Nature Communications

P1476

Global site-specific N-glycosylation analysis of HIV envelope glycoprotein

@en

P2093

Ching Yao Su

http://www.w3.org/2001/XMLSchema#string

Claire M Delahunty

http://www.w3.org/2001/XMLSchema#string

Daniel W Kulp

http://www.w3.org/2001/XMLSchema#string

Dennis R Burton

http://www.w3.org/2001/XMLSchema#string

Devin Sok

http://www.w3.org/2001/XMLSchema#string

Erik Georgeson

http://www.w3.org/2001/XMLSchema#string

James C Paulson

http://www.w3.org/2001/XMLSchema#string

Javier Guenaga

http://www.w3.org/2001/XMLSchema#string

Jolene K Diedrich

http://www.w3.org/2001/XMLSchema#string

Lin He

http://www.w3.org/2001/XMLSchema#string

P2860

Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding

Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env

Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility

Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies

Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors

Broadly Neutralizing Antibody PGT121 Allosterically Modulates CD4 Binding via Recognition of the HIV-1 gp120 V3 Base and Multiple Surrounding Glycans

Structural basis for diverse N-glycan recognition by HIV-1–neutralizing V1–V2–directed antibody PG16

Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer

Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer

P2888

P304

14954

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCOMMS14954

http://www.w3.org/2001/XMLSchema#string

P407

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Matthias Pauthner

P577

2017-03-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28348411

http://www.w3.org/2001/XMLSchema#string

P921

P932

5379070

http://www.w3.org/2001/XMLSchema#string